Market News Latest

CD Genomics Upgrades Highly Accurate and Sensitive Single-Cell Sequencing Services for Genome Researchers

 Breaking News
  • No posts were found

CD Genomics Upgrades Highly Accurate and Sensitive Single-Cell Sequencing Services for Genome Researchers

July 03
16:04 2019

SHIRLEY, NY, USA – Jul 3, 2019 – CD Genomics, an expert in transcriptomics and next-generation sequencing company, announces the technical escalation of its single-cell sequencing services. Supported by a committed and professional multifunctional team specialized in genome sequencing, CD Genomics is capable of offering high-quality single-cell sequencing services to biologists and global markets.

At CD Genomics, Single-cell sequencing is an emerging and powerful technology that will undoubtedly help to better understand the complex genetic variation within individual cells. “Our single-cell RNA sequencing (scRNA-seq) has recently undergone fast advances in the development of this technology, leading to high throughput and accelerated the discovery of many biological systems and diseases. The single-cell resolution of this technique allows for the study of the heterogeneity of cell populations as well as the precise localization of pathological populations that lead to disease, such as cancers,” stated by CD Genomics’ executive vice president.

There are many applications for scRNA-seq in CD Genomics:

  1. It provides some information about cells and diseases. The use of scRNA-seq on tumor cells allows tumor fibroblasts to be isolated from endothelial cells and cancer cells based solely on their gene expression characteristics.
  2. scRNA-seq can also be used to study the development of organs and tissues. A better understanding of the exact gene expression programs that drive differentiation pathways leading to different cell types will improve understanding of organ development.

Since cancer biology is one of the research areas that benefit from single-cell DNA sequencing applications, CD Genomics is committed to providing high-precision such services to researchers. Tumors are mosaics produced by different clones, and single-cell DNA sequencing is a powerful tool for tracking the progress and expansion of individual clones. Furthermore, single-cell DNA sequencing allows researchers to study genetic alterations in rare cell types, such as cancer stem cells, which are important for tumor recurrence. In addition to single-cell DNA sequencing, CD Genomics also provides high-quality single-cell DNA methylation sequencing to quantify DNA methylation, which focuses on the links between cell variation in tissues and organ function and further elucidates the origins of diseases.

“CD Genomics concentrates on supplying high-quality services and products for labs and research institutes. We guarantee the developed products and services, which are customized, can meet the demands of our clients, who believe in our scientists and CD Genomics,” said Dr. David.

About CD Genomics

As one of the world-leading genomics services company, CD Genomics innovates sequencing services, as well as genotyping, library construction, bioinformatics, aptamers, microarray, health diagnostics, mutagenesis analyses and others for the genomics industry.

Media Contact
Company Name: CD Genomics
Contact Person: Kiko Garcia
Email: Send Email
Phone: 6316197922
Address:45-1 Ramsey Road
City: Shirley
State: New York
Country: United States